Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Ascensia Diabetes Care
MedTech
Senseonics to retake Eversense commercial control from Ascensia
Senseonics aims to speed up the commercial rollout of its latest, yearlong CGM sensor implant, the Eversense 365.
Conor Hale
Sep 5, 2025 2:00pm
FDA clears Senseonics' 365-day Eversense CGM implant
Sep 17, 2024 11:00am
Ascensia adds automated food analysis to glucose monitors
Feb 22, 2023 1:04pm
Ascensia's online diabetes analytics platform makes US debut
Nov 2, 2022 10:27am
Ascensia completes European launch of Eversense 6-month CGM
Oct 10, 2022 10:22am
Senseonics' 180-day glucose sensor scores new European approval
Jun 16, 2022 11:55am
